Regulatory
Mitsubishi Tanabe’s Edaravone Receives NMPA’s Approval for Amyotrophic Lateral Sclerosis
Shots: Post MHLW approval in Japan in 2015, the company has received NMPA approval for Edaravone and is approved in six countries of China. Additionally, the product is approved in […]readmore